Who are Simbryotech's investors?

Simbryotech's investors include Keyhorse Capital, TSVC.

How much funding has Simbryotech raised?

Simbryotech has disclosed $5.3M raised across 1 of its 2 known rounds.

Where is Simbryotech headquartered?

Simbryotech is headquartered in Houston, US.

Simbryotech

Houston, US · Founded 2023 · 2 known investors

Find your way into Simbryotech

Paths you didn't know you had: your email and LinkedIn already hold routes to the Simbryotech team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Simbryo Technologies is a biotech company that creates endometrial organoids from a patient's own stem cells using a routine biopsy, offering functional diagnostic tests of the uterine lining to assess and optimize endometrial fertility. Working with research institutions and fertility clinics, it uses organoid medicine and AI to give patients and physicians insights aimed at improving IVF success rates and to serve as a test bed for new fertility treatments.

AI & Machine Learning Biotech Digital Health FemTech Medical Devices

Founders & leadership

Yael Katz Founder & CEOExecutive Officer, Director at BrainCheck

Aryeh WarmflashNamed on SEC filing

Stephen RooksNamed on SEC filing

Andrea Mazzocchi Board MemberCo-founder, PhD at Known Medicine

Investors · 2

Keyhorse Capitallisted by Keyhorse CapitalLexington

How we know: Keyhorse Capital's portfolio page · Not right? Tell us

TSVClisted by TSVCSilicon Valley · $1M

How we know: the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$5.3M disclosed across 1 of 2 rounds · 2025–2026

▶$5.3MraisedJul 2026 · 24 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Yael KatzExecutive Officer, Director
Aryeh WarmflashExecutive Officer
Stephen RooksDirector
Andrea MazzocchiDirector

Offering amount: $5.3M
Amount sold: $5.3M
First sale: Sep 2025
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Simbryotech went on to found or lead other companies.

Andrea MazzocchiDirectorFounded Paceline Bio +1 Yael KatzExecutive Officer, DirectorFounded BrainCheck

Related companies · 5

ZibrioZIBRIO develops a balance assessment technology using machine learning to measure postural stability through a one-minute standing test, designed for both self-administration and clinical settings to identify fall risk in older adults. The company serves healthcare providers and older adults seeking fall prevention and balance monitoring.

Los Angeles ProjectBuilding.life uses genetic engineering, genomic analysis, and AI to design novel organisms, beginning with engineering the world's first true unicorn through precision gene editing and embryonic development.

Pano AIPano develops artificial intelligence and machine learning technology solutions to help utility companies and fire agencies detect and manage wildfire threats. The company serves emergency managers and professionals in the utility and fire industries seeking to protect communities from wildfires.

SimbiosysSimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning. Its tools serve breast cancer surgeons and clinicians for preoperative planning and analysis in oncology.

Insitroinsitro is a drug discovery and development company that uses machine learning and cellular data to identify therapeutic insights and accelerate the creation of new medicines. The company serves patients and pharmaceutical development by integrating in vitro lab data with human clinical data to decode biology and unlock transformative treatments.

Companies working in the same space as Simbryotech.

Frequently asked questions

What does Simbryotech do?: Simbryo Technologies is a biotech company that creates endometrial organoids from a patient's own stem cells using a routine biopsy, offering functional diagnostic tests of the uterine lining to assess and optimize endometrial fertility. Working with research institutions and fertility clinics, it uses organoid medicine and AI to give patients and physicians insights aimed at improving IVF success rates and to serve as a test bed for new fertility treatments.
Who are Simbryotech's investors?: Simbryotech's investors include Keyhorse Capital, TSVC.
How much funding has Simbryotech raised?: Simbryotech has disclosed $5.3M raised across 1 of its 2 known rounds.
Where is Simbryotech headquartered?: Simbryotech is headquartered in Houston, US.